Sanofi SA (NASDAQ:SNY)

42.57
Delayed Data
As of Aug 22
 -0.63 / -1.46%
Today’s Change
40.00
Today|||52-Week Range
45.62
-1.94%
Year-to-Date
Pfizer's Xtandi Label Expansion Filing Gets Priority Review
Aug 22 / Zacks.com - Paid Partner Content
Should Value Investors Consider Sanofi (SNY) Stock Now?
Aug 14 / Zacks.com - Paid Partner Content
Is Sanofi (SNY) a Great Value Stock Right Now?
Aug 22 / Zacks.com - Paid Partner Content
J&J's Tuberculosis Drug Gets FDA Nod for Adolescent Patients
Aug 12 / Zacks.com - Paid Partner Content
Inovio Ends Enrollment in Anal Dysplasia Study on VGX-3100
Aug 20 / Zacks.com - Paid Partner Content
AnaptysBio Prepares for a Potential Gear Shift
Aug 10 / MotleyFool.com - Paid Partner Content
Regeneron Gets FDA Nod for Eylea Injection Prefilled Syringe
Aug 15 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close43.20
Today’s open42.85
Day’s range42.55 - 42.96
Volume979,319
Average volume (3 months)1,442,026
Market cap$104.7B
Data as of 4:00pm ET, 08/22/2019

Growth & Valuation

Earnings growth (last year)+19.94%
Earnings growth (this year)+4.43%
Earnings growth (next 5 years)+4.50%
Revenue growth (last year)+2.83%
P/E ratio26.9
Price/Sales2.68
Price/Book1.55

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.15+0.13%
GSKGlaxoSmithKline+0.29+0.71%
ABBVAbbVie-0.02-0.03%
AZNAstraZeneca-0.01-0.02%
Data as of 6:30pm ET, 08/22/2019

Financials

Next reporting dateOctober 31, 2019
EPS forecast (this quarter)$1.00
Annual revenue (last year)$40.7B
Annual profit (last year)$5.1B
Net profit margin12.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Olivier Brandicourt
Chief Financial Officer &
Executive Vice President
Jean-Baptiste Chasseloup de Chatillon
Corporate headquarters
Paris, Ile-de-france

Forecasts